BioSig Raises $1.1B for Revolutionary Gold-Backed Blockchain Platform
BioSig Technologies and Streamex Exchange Merge to Revolutionize Gold Bullion Market
Major Merger Announcement
BioSig Technologies, Inc. (Nasdaq: BSGM) has officially merged with Streamex Exchange Corporation, positioning itself as a leading public entity in gold bullion holdings. This strategic alliance aims to leverage the strengths of both companies to reshape the landscape of global finance.
- Major Merger Announcement
- Transforming Commodities with blockchain
- Financing for Growth
- Details of the Financing Agreement
- Anticipated Closing and Future Prospects
- Leadership Insights
- Market Outlook and Strategic Positioning
- Commitment to Gold Holdings
- Expert Opinions on Gold’s Future
- Experienced Leadership Team
- About BioSig Technologies, Inc.
- About Streamex Exchange Corporation
- Forward-Looking Statements
- Contact Information
Transforming Commodities with blockchain
Streamex is set to introduce its innovative real-world asset (RWA) platform, which will integrate the vast $142 trillion commodities market onto the blockchain, utilizing the capabilities of Solana. This merger is expected to enhance the efficiency and transparency of commodity transactions.
Financing for Growth
The newly formed entity has secured definitive agreements with a prominent institutional investor for growth financing of up to $1.1 billion. This funding will enable BioSig to solidify its status as a major player in the gold market, facilitating the tokenization of real-world assets.
Details of the Financing Agreement
The agreement includes the issuance of $100 million in senior secured convertible debentures and a $1 billion equity line of credit. The debentures will mature in 24 months and carry an interest rate of 4% per annum, which may increase to 18% in the event of a default. The company will also provide a first priority lien on certain assets as collateral.
Anticipated Closing and Future Prospects
The closing of the $75 million debenture offering is projected for October 7, 2025, pending shareholder approvals and customary closing conditions. The remaining $25 million will follow, contingent on specific closing requirements. This financial maneuver is expected to enhance the company’s position as a gold treasury firm while investing in RWA blockchain technology.
Leadership Insights
Henry McPhie, CEO of BioSig and Co-Founder of Streamex, emphasized the significance of this financing, stating it marks a crucial step in the evolution of financial markets. By merging physical gold with blockchain innovation, the company aims to unlock new levels of liquidity and accessibility in the commodities market.
Morgan Lekstrom, Co-Founder of Streamex and Chairman of BioSig, highlighted the transformative potential of integrating gold and commodities on-chain, presenting a unique value proposition for token holders.
Market Outlook and Strategic Positioning
Streamex anticipates that RWA tokenization, particularly in gold, will surpass Bitcoin in importance, driven by a favorable outlook for gold prices and increasing adoption by traditional financial institutions. The daily trading volume in gold bullion significantly exceeds that of Bitcoin, indicating a robust market opportunity.
Commitment to Gold Holdings
The company plans to maintain substantial gold bullion reserves, secured through partnerships with top-tier bullion banks. By prioritizing vaulted physical gold over fiat currency, Streamex aims to create a scalable revenue model through gold-backed tokens, offering investors efficient access to gold investments.
Expert Opinions on Gold’s Future
Strategic Advisor Frank Giustra expressed confidence in gold as a hedge against various risks, suggesting that its current performance reflects broader economic conditions. Sean Roosen, another strategic advisor, believes Streamex represents a new frontier in mining finance, utilizing modern solutions to attract investment and enhance transparency.
Experienced Leadership Team
The leadership team at Streamex, led by CEO Henry McPhie and Chief Investment Officer Mitch Williams, boasts extensive experience in the fields of cryptocurrency, technology, and institutional investing. Their backgrounds include significant roles at major financial institutions and companies, positioning Streamex for success in the evolving market landscape.
About BioSig Technologies, Inc.
BioSig Technologies specializes in advanced medical device technology, particularly its PURE EP™ Platform, which enhances the precision of electrophysiological procedures. The platform aims to improve procedural outcomes while minimizing costs.
About Streamex Exchange Corporation
As a subsidiary of BioSig, Streamex focuses on RWA tokenization in the commodities sector. The company is dedicated to bridging traditional finance with digital innovation, enhancing market liquidity and accessibility.
Forward-Looking Statements
This announcement contains forward-looking statements that are subject to various risks and uncertainties. Actual results may differ significantly from those anticipated, depending on several factors, including shareholder approval and compliance with Nasdaq listing criteria.
Contact Information
For further inquiries, please reach out to:
Press Contact:
Johanna Hoopes
Email: [email protected]
Investor Relations:
BioSig Technologies, Inc.
12424 Wilshire Blvd Ste 745
Los Angeles, CA 90025
Email: [email protected]
Phone: 203-409-5444, x104
CEO Contact:
Henry McPhie
Email: [email protected]
Website: Streamex
This merger marks a significant milestone in the evolution of financial markets, with the potential to redefine how commodities are accessed and valued in the digital age.
